Search Results < Laboratory Medicine

36 results

News
ExPath Grad Student Madeline Mayday Awarded Grant from the NIDDK Cooperative Centers of Excellence in Hematology
Madeline Mayday, BS, a fourth-year Experimental Pathology graduate student in the Laboratory of Diane Krause, MD, PhD, was recently awarded a 2022 National Institute of Diabetes and Digestive and Kidney Diseases Hematology Centers Program Type B Pilot and Feasibility grant
20 Sep 2022
News
What Platelets and Endothelial Cells May Reveal About the Coronavirus Disease
Yale researchers have helped identify the mechanisms behind a major cause of morbidity and mortality in COVID-19 patients.
19 Nov 2020
News
Eisenbarth receives the National Blood Foundation Award for Innovative Research
Eisenbarth receives the 2017 National Blood Foundation Award for Innovative Research
13 Dec 2017
News
Yale Cooperative Center of Excellence in Hematology established by new NIH grant
Yale Cooperative Center of Excellence in Hematology
27 Jan 2016
News
Dr. Markus Müschen Elected to CASE
Markus Müschen, MD, PhD, Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology, has been elected to Connecticut Academy of Science and Engineering (CASE) for 2023.
3 Mar 2023
News
National Registry May Reduce Mortality Among Alloimmunized People with Sickle Cell Disease
A nationwide red blood cell alloantibody exchange could reduce mortality among alloimmunized individuals with sickle cell disease, according to study results presented at ASH Annual Meeting and Exposition. Use of a national system to share data from blood transfusions also could reduce the cost of care for this population, investigators concluded
Source: Healio
15 Dec 2022
News
Sickle Cell Cure will be Cost-Effective if Health Disparities Considered -Study Finds
Dec 13 (Reuters) - Multimillion-dollar gene therapies being tested for sickle cell disease will be cost-effective in the United States if health disparities tied in part to decreased access to healthcare are taken into account, researchers said at a meeting of blood-disease specialists.
Source: Reuters
13 Dec 2022
News
Gene Therapy May be Equitable Therapeutic Option for Sickle Cell Disease in US
Gene therapy could represent an equitable therapeutic strategy for sickle cell disease in the United States, according to study results presented at ASH Annual Meeting and Exposition.
Source: Healio News
11 Dec 2022
News
The Unknown Puts Offspring At Risk Of Sickle Cell Disease
Most Connecticut residents who carry a trait for sickle cell disease don’t know it, resulting in thousands of people unwittingly risking having a child born with the debilitating illness, according to sickle cell disease specialists.
Source: CT News Junkie
2 Nov 2022
News
Sickle Cell Disease Has Long Been Misunderstood. These Firefighters Want to Change That.
The history of sickle cell disease goes back about 4,000 years to when humans began harvesting rice, according to Dr. Lakshmanan Krishnamurti, an MD in Hematology-Oncology at Yale New Haven Children’s hospital.... Sickle cell disease has long been misunderstood. These firefighters want to change that. New Haven Fire Department Lt. Samod Rankins, James Rawlings, president and CEO of Sickle Cell Disease Association of America, Connecticut, and retired New Haven Fire Department Capt. Gary Tinney.
Source: New Haven Register
24 Sep 2022
News
Stem Cell Treatment Offers Hope — And High Costs — For Retired Farmington Teacher With Aggressive Forms Of Cancer
John has been at Yale New Haven Hospital since the beginning of July to prepare, undergo and recover from a stem-cell transplant to treat non-Hodgkin Lymphoma. His recovery is going as planned, but isn’t an easy road.
Source: Yahoo! News
23 Jul 2022
News
Health & Veritas: Hope for Sickle Cell Patients (Ep. 25)
On the Health & Veritas podcast, Yale physician-professors Howard Forman and Harlan Krumholz talk about the latest news and ideas in healthcare and seek out the truth amid the noise. In the latest episode, they’re joined by Dr. Lakshmanan Krishnamurti, chief of pediatric hematology and oncology at the Yale School of Medicine and an expert on sickle cell disease.
Source: Yale Insights
17 Mar 2022
News
Bernard G. Forget Hematology Scholars Program Supported by Friends who Give
Mary Alice and Thomas O’Malley’s recent gift to support Yale’s Bernard G. Forget Hematology Scholars Program is rooted in multiple friendships. The couple learned about the program from their friend Alan Lebowitz, MD., who was Associate Clinical Professor of Medicine at Yale School of Medicine and is a retired Connecticut hematologist. Dr. Lebowitz, a champion of Yale Cancer Center, was also a close friend of the Scholars Program’s late namesake.
25 May 2021
News
Blood Tests Offer Early Indicator of Severe COVID-19, Study Says
In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients.
26 Feb 2021
News
Convalescent Plasma for Severe COVID-19: D-Dimer Level After Transfusion May Be a Predictive Biomarker of Mortality
Researchers characterized the outcomes seen in patients hospitalized with severe coronavirus disease 2019 (COVID-19) after infusion with convalescent plasma (CP), and the results were presented during the virtual 62nd American Society of Hematology (ASH) Annual Meeting and Exposition.
Source: Cancer Therapy Advisor
6 Dec 2020
News
Prevalence of Endotheliopathy in COVID-19–Associated Coagulopathy
Among patients with COVID-19–associated coagulopathy, endotheliopathy may be linked to critical illness and death.
Source: The Cardiology Advisor
26 Aug 2020
News
Amer Zeidan, MBBS, MHS, Discusses Efficacy of Azacitdine Plus Durvalumab for AML and MDS
At the 2019 ASH Annual Meeting, Amer M. Zeidan, MBBS, MHS, Yale University and Yale Cancer Center, New Haven, Connecticut, discusses results from a large, international, randomized phase 2 study exploring azacitidine plus durvalumab for older patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS) who are unfit for intensive chemotherapy.
Source: Oncology Learning Network
17 Dec 2019
News
Yale Cancer Center researchers show identifying type of chronic pain in adults with sickle cell disease may lead to better outcomes
Identifying the type of pain an adult with sickle cell disease (SCD) experiences may be useful in improving treatment, according to a new study by researchers at Yale Cancer Center (YCC) and Smilow Cancer Hospital.
6 Dec 2019
News
Department of Neurology Receives Major Grant to Evaluate Blood Thinners and Stroke Prevention
Yale School of Medicine has received a 5-year, $20 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to administer a Phase III trial measuring the effectiveness of using a blood thinner to prevent new strokes in patients who suffered brain hemorrhages and have atrial fibrillation, or irregular heartbeat.
3 Jul 2019
News
Yale Researchers Crack the Code of a Rare, Inherited Anemia
Yale pediatrician and geneticist Patrick Gallagher, M.D., studies hereditary spherocytosis (HS), an inherited disease associated with hemolytic anemia, when red blood cells are destroyed faster than they are produced due to abnormal membranes. A novel mutation in the gene that encodes alpha-spectrin, a protein essential for normal red blood cell membranes, is responsible for many cases of recessive hereditary spherocytosis (rHS), the most severe form of the disease, reports Gallagher’s team
2 Jul 2019